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Background: Only a few case reports and case series dealing with oral and dental health care are available in
literature until now. The aim of the present pilot study was to determine the status of dental health in comparison
to matched controls and to heighten the neurologists’ and dentists’ awareness of the oral aspects of the disease.
Methods: 42 Huntington’s disease (HD) participants were scored according to the Unified Huntington’s Disease
Rating Scale. The dental status was assessed by using the well established score for decayed, missing, and filled
teeth (DMFT) and the dental plaque score (Silness-Loe plaque index).
Results: Compared to controls HD participants showed significantly more decayed teeth and more plaques in both
plaque indices. A higher motor impairment and a lower functional status of the patients lead to a worsening in
dental status.
Conclusion: Possible reasons for our findings are discussed. Apart from local oral complications general
complications may also occur. Thus, as a consequence, we would encourage patients, caregivers, neurologists, and the
dentists to ensure regular preventive dental examinations and dental treatments of individuals with Huntington’s
disease even in the premanifest stage of this disease.Background
Only a few data exist to indicate oral and dental health
in patients with Huntington’s disease (HD). A search in
PubMed/MEDLINE using the terms “Huntington dental”,
“Huntington teeth” or “Huntington tooth” provided ten
hits dealing with this subject [1-10]. Some of these cases
report on different anesthesia techniques in order to
enable dental treatment and/or the treatment of the
single HD cases (e.g. by using implant-supported denture).
To our clinical impression dental health care seems to
be extremely insufficient in a large number of subjects
suffering from HD (see Figure 1).
Problems caused by HD are accentuated by the dentist’s
lack of neurological knowledge (i.e. pharmacological ther-
apy, clinical fluctuations of drug therapy, and behavioural
aspects) and the neurologist’s lack of awareness of many
of the pathological changes in the oral cavity (i.e. oral and* Correspondence: carsten.saft@ruhr-uni-bochum.de
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Jackowski and colleagues stated in their case report
that patients with extrapyramidal diseases, such as HD,
are often not capable of maintaining independent and
efficient oral hygiene due to restricted motor ability of
the upper extremities and lack of coordination. The
hermetic closure of the mouth and lips and the associated
ability to keep liquid and toothpaste in the mouth might
be impaired and, thus, an effective oral hygiene cannot be
maintained. Moreover dyskinesia and hyperkinesia of the
tongue and of the perioral musculature, combined with
xerostomia and pooling of saliva, may have an influence.
Finally, the different factors lead to a poor oral health
status and loss of teeth. In the reported case an implant-
supported complete denture led to a clear improvement
in the patient's chewing function [3].
Deniz and colleagues mentioned cognitive decline and
behavioural manifestations of the disease as well as
medication side-effects as possible additional reasons
contributing to a poor dental care status. In this case
report, the patient was rehabilitated with a mandibular
overdenture supported by two endosteal implants [2].. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Example of a disastrous dental status in the lower jaw of a 71 year old patient suffering from Huntington’s disease for five
years not included in the study. Extensive parodontitis, avital and carious teeth with plaques and osseous involvement are obvious. This
patient did not complain of any dental pain and refused treatment.





Sex (male/female) 21/21 21/21
Age of onseta) 39.0±11.3
motor symptoms (20–63) -
Age of onset 38.0±11.1
psychiatric symptomsb) (20–63) -
Duration of motor symptomsa) 7.31±3.72 -
(2–18)
Duration of psychiatric 7.72±4.67 -
symptomsb) (1–22)
UHDRS MS 45.3±21.1 -
(0–81)
UHDRS TFC 7.5±3.2 -
(2–13)




Values are given as mean and standard deviation, as well as the range in
brackets. Abbreviations: UHDRS, unified Huntington’s disease rating scale; IS,
independence scale; TFC, total functional capacity; MS, motor score; MMSE,
mini-mental state examination. Missing data for the three premanifest
participantsa); Missing data for 11 participantsb).
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case reports, the aim of this study was to evaluate the
status of dental health in comparison to matched controls
in HD.
Methods
42 HD participants and matched healthy controls were
included in the study. Controls were recruited from
partners of the patients or via an announcement. Diagnosis
of HD was confirmed by molecular genetic testing in 41
patients, three subjects were premanifest mutation
carriers. One patient was diagnosed clinically and by a
positive family history. Subjects with symptoms of a severe
dementia (Mini-Mental State examination < 10) or other
severe concomitant disorders, influencing their ability
to declare consent, were excluded. The mean duration
of the disease was 6.3 years. HD-symptoms were scored
according to the Unified Huntington’s Disease Rating Scale
(UHDRS), including the subscales for motor symptoms
(MS), total functional capacity (TFC) and Independence
scale (IS). Premanifest mutation carriers were defined
by a positive gene test and absence of unequivocal motor
symptoms according to the UHDRS diagnostic confidence
level (DCL: < 4) [11]. The Mini-Mental State examination
(MMSE) was performed for assessment of the cogni-
tive status of the participants [12]. Recruitment of the
subjects was carried out blinded to the dental status of the
participants. Detailed data of subjects are given in Table 1.
The two established World Health Organization-ap-
proved dental indices for decayed, missing, and filled
teeth (DMFT; 1938) and the dental plaque score (PI)
developed by Silness and Loe (1964) were selected to
quantify dental disease [13-15].
Table 2 Dental status of HD participants and controls
assessed by the DMFT score (1938) for decayed, missing
and filled teeth and Plaque indices score after Silness
and Loe (1964)
HD Controls Significance
DMFT decayed 2.98±3.10 0.71±1.09 < 0.05
(0–10) (0–4)
DMFT missing 4.88±6.84 4.12±5.83 NS
(0–28) (0–28)
DMFT filled teeth 10.29±5.43 12.02±5.02 NS
(0–22) (0–23)
DMFT sum score 18.14±6.13 16.88±6.06 NS
(6–28) (3–28)
Plaque Indices Ia) 1.88±0.89 0.95±0.62 < 0.05
(0.14-3.0) (0–2.60)
Plaque Indices IIa) 1.92±0.89 1.15±0.64 < 0.05
(0.14-3.0) (0–2.50)
a)Plaque indices were assessed for only 41 HD participants.
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caries, including the number of present teeth, missing teeth,
sound teeth, treated teeth, untreated teeth, and the total
number of carious teeth (DMF teeth: decayed, missing, and
filled teeth). For the PI score teeth surfaces were given a
score from 0 (no plaque) to 3 (abundance of soft matter
within the gingival pocket and/or on the tooth and gingival
margin). The index was obtained by calculating the mean
for all investigated teeth and surfaces. PI-I was used for the
mean of all teeth of the patient, PI-II for the mean of
defined index-teeth. The teeth 17, 16, 11, 24, 26, 27, 37,
36, 31, 44, 46 and 47 were used for analysis according to
the method described before [13]. If one of the index
teeth was missing, the next adjacent tooth wase used for
evaluations. Plaque indices were only possible to assess for
41 HD participants, because one patient refused further
investigation.
Statistical analysis was performed using the commercial
software program SPSS statistics. All measured parameters
and clinical data were first analysed descriptively and are
presented as mean ± SD. Normality of distribution of the
data was tested using the Shapiro-Wilk-test. Independent
t-test, respectively Mann–Whitney-U-test, was used to
test for differences between the two groups. Bonferroni
correction was used for multiple testing. Spearman-Rho
correlation analysis was used for exploratory statistical
correlation analysis. All participants gave written informed
consent.Ethics
The local ethics committee of the Ruhr University Bochum
approved this study.Results
HD participants showed significantly more decayed teeth
than controls. Differences in the DMFT score for missed
and filled teeth, however, failed to reach a significant
level. HD participants also showed significantly more
plaque in both plaque indices compared to controls. All
results of DMFT score and the plaque indices are given
in Table 2 in detail.
No differences between male and female HD participants
were found. Explorative correlation analysis of DMFT and
plaque indices (PI) results given in Table 2 with clinical
symptoms showed no significant correlation with any of
the clinical characteristics from Table 1, except for the
UHDRS motor score and missing teeth (p 0.025, r .345),
PI-I (p 0.009, r .404) and PI-II (p 0.006, r .426). The age of
onset of motor symptoms showed a significant correlation
with missing teeth (p 0.006, r .432), as did the psychiatric
onset (p 0.020, r .416) and the TFC score correlated
negative with the plaque scores (PI-I: p 0.001, r - .501; PI-II:
p 0.001, r - .503).Discussion
To our best knowledge, this, present study is one of only
a few reporting on dental health in HD. The results
support our hypothesis that the dental health status is
impaired in HD compared to controls. In particular, HD
participants showed significant more decayed teeth and
plaques as controls. A causal relationship between the
dental status and HD is only partly supported by the correl-
ation between UHDRS subscales and scores of the DMFT
and PI scores. A lower functional status of the patients lead
to a worsening in dental health (higher plaque scores).
There was, however, no correlation between a higher
plaque score or decayed teeth and the UHDRS motor
score. Thus only an indirect interrelation between dental
health and movement disorders could be found. We did
not analyse the chorea subscore and parameters of dental
health. The weak positive correlation with the age of
onset might reflect an additional effect of age. To our
surprise, there was no correlation between dental status
and duration of the disease, which might be explained
by an impaired oral health in the premanifest stage
already.
An inefficient oral hygiene due to restricted motor ability
of the upper extremities, a lack of coordination and/or an
impairment of the hermetic closure of the mouth and lips
due to more dys- and hyperkinesia of the tongue and of
the perioral musculature might contribute to the impaired
dental health status in HD [3]. We could not reveal any
correlation between dental status and the mini-mental
score and, therefore, we are not able to underline the thesis
of cognitive decline as a reason for an impaired teeth
status. This might also be due to the relative small number
of patients investigated in this pilot-study. Because of
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medication or smoking as possible influencing factors,
nor did we analyze behavioural manifestations of the
disease (e.g. using an apathy score) as reasons for the
poor dental status, which is a clear limitation of our
study. We also did not ask how frequently the patients
cleaned their teeth compared to controls. All factors,
however, might contribute, especially apathy may be a
reason for a lack of dental hygiene even in premanifest
stages of the disease [16,17]. Moreover, an impaired
awareness of a poor dental status might be an explanation,
since an impaired awareness of motor, functional and
cognitive deficits is known in HD [18,19]. As an additional
possible reason an altered sensory processing and lack of
pain recognition might contribute [20,21]. Salivation can
be altered due to medication effects but also due to altered
autonomic function and hormonal influences [22-25].
In more advanced stages of the disease also dysphagia,
vomiting and regurgitation influences the dental status
[26]. Thus, influences from the disease itself as well as
secondary mechanisms like malnutrition, medication
and general disability may contribute.
We also found a lower score for filled teeth, that is for
treated teeth by a dentist and a higher level of missing
teeth in the HD group. Both findings, however, failed to
reach statistical significance. The lower scores might be
explained by a higher rate of tooth extraction or due to
trauma and the consequence of falls, which is supported
by the correlation of missing teeth with the UHDRS
motor score. A poorer dental status may lead earlier to a
tooth extraction as the only causal therapy in HD patients.
It is discussed whether the dental care status predicts
circulatory mortality and other causes of death. As
possible pathways, the effects of masticatory dysfunction
on dietary behaviour, nutrition and systemic diseases and
inflammatory effects on the circulatory system are
discussed [27-29]. Oral disease was found to be associated
with excess cardiovascular disease risk, with possibly
common pathogenetic mechanisms between poor oral
health and cardiovascular disease [30].
In some cases "a bad tooth" was discussed as the
cause of premature death (e.g. in the case of Theodore
Roosevelt (1858–1919) the twenty-sixth President of
the United States who anecdotally died from oral sepsis)
[31,32]. Thus, beside local complications it cannot be
excluded that the impaired dental status in HD leads to
an earlier death directly or by triggering cardiovascular
diseases [33,34].
Conclusions
Preventive dentistry is the most important aspect of dental
treatment for the person with Huntington’s disease,
as with all patients. Although the goals of preventive
dentistry include self-sufficiency, the spouse or caregivermust be educated to supervise and evaluate hygiene pro-
cedures daily at home. As HD progresses, patients become
increasingly incapable of completing even the simplest
forms of oral care. The primary goals of dental treatment
planning should be maintenance of natural dentition, early
intervention, regular preventive treatment and preserva-
tion of self-care. HD subjects in any stage of the disease
should see a dentist at least every 4 months whether
they have natural teeth, complete dentures, or a mixture
of teeth and dentures. Pathological conditions may be
diagnosed early and treated in simple stages. When
clinical findings suggest Huntington’s disease, the patient
should be referred for oral and dental evaluation. Oral
health parameters, including salivary flow gingival health
(bleeding, plaque, calculus), periodontal health (pocket
depth, recession, loss of attachment), and dental condition
(number of teeth, decay, restored), must be measured at
onset (baseline) and course of the disease. Some authors
also recommend to visit the same dentist over time, if
possible [4].
Competing interests
Carsten Saft received honorarium from Temmler Pharma GmbH & Co..KG for
scientific talks, compensation in the context of the Registry-Study of the
Euro-HD-Network, in the context of the ACR16-Study (Neurosearch), the
AFQ-Study (Novartis), the Selisistat-Studies (Siena Biotech) and received
research support for a research project with Teva Pharma GmbH and the
'Cure Huntington's Disease Initiative (CHDI Foundation, Inc.). Julia Becker,
Thomas Müller, Jürgen Andrich and Jochen Jackowski has nothing to
declare. The authors declare that they have no competing interests.
Authors’ contributions
Study concept and design: JEA, TM and JJ. Acquisition of data: CS, JB and
JEA. Analysis and interpretation of data: JB, CS and JEA. Statistical analysis: JB
and CS. Drafting of the manuscript: CS. Critical revision of the manuscript for
important intellectual content: JEA, TM and JJ. All authors read and approved
the final manuscript.
Acknowledgement
We are grateful to all patients for participation.
Funding
Carsten Saft was supported by a FoRUM grant, University of Bochum
(AZ: K040-2009).
Author details
1Department of Neurology, Huntington-Center NRW, St. Josef Hospital, Ruhr
University, Gudrunstrasse 56, 44791 Bochum, Germany. 2Department of Oral
Surgery and Dental Emergency Care, Dental School, Faculty of Health,
Witten/Herdecke University, Witten, Germany.
Received: 11 March 2013 Accepted: 29 August 2013
Published: 3 September 2013
References
1. Boyle CA, Frolander C, Manley G: Providing dental care for patients with
Huntington's disease. Dent Update 2008, 35(5):333–336.
2. Deniz E, Kokat AM, Noyan A: Implant-supported overdenture in an elderly
patient with Huntington's disease. Gerodontology 2011, 28(2):157–160.
3. Jackowski J, Andrich J, Kappeler H, Zöllner A, Johren P, Muller T: Implant-
supported denture in a patient with Huntington's disease:
interdisciplinary aspects. Spec Care Dentist 2001, 21(1):15–20.
4. Kieser J, Jones G, Borlase G, MacFadyen E: Dental treatment of patients
with neurodegenerative disease. The New Zealand Dent J 1999,
95(422):130–134.
Saft et al. BMC Neurology 2013, 13:114 Page 5 of 5
http://www.biomedcentral.com/1471-2377/13/1145. da Fonseca MA, Walker PO: Dental management of a child with
Huntington's disease: case report. Spec Care Dentist 1993, 13(2):71–73.
6. Rada RE: Comprehensive dental treatment of a patient with Huntington's
disease: literature review and case report. Spec Care Dentist 2008,
28(4):131–135.
7. Bradford H, Britto LR, Leal G, Katz J: Endodontic treatment of a patient
with Huntington's disease. J Endod 2004, 30(5):366–369.
8. Cangemi CF Jr, Miller RJ: Huntington's disease: review and anesthetic case
management. Anesth Prog 1998, 45(4):150–153.
9. Feeney AW: Dental treatment considerations for patients with
Huntington's chorea: a literature review and case report. J Conn State
Dent Assoc 1985, 59(4):118–123.
10. Moline DO, Iglehart DR: Huntington's chorea: review and case report.
Gen Dent 1985, 33(2):131–133.
11. Huntington SG: Unified Huntington's disease rating scale: reliability and
consistency. Huntington study group. Mov Disord 1996, 11(2):136–142.
12. Folstein MF, Folstein SE, McHugh PR: Mini-mental state. A practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res 1975, 12(3):189–198.
13. WHO Collaborating Centre for Education, Training and Research at the Faculty
of Odontology. http://www.whocollab.od.mah.se.
14. Silness J, Loe H: Periodontal disease in pregnancy. Ii. Correlation between
oral hygiene and periodontal condtion. Acta Odontol Scand 1964,
22:121–135.
15. Sheiham A, Sabbah W: Using universal patterns of caries for planning and
evaluating dental care. Caries Res 2010, 44(2):141–150.
16. Craufurd D, Thompson JC, Snowden JS: Behavioral changes in Huntington
disease. Neuropsychiatry Neuropsychol Behav Neurol 2001, 14(4):219–226.
17. Kingma EM, van Duijn E, Timman R, van der Mast RC, Roos RA: Behavioural
problems in Huntington's disease using the problem behaviours
assessment. Gen Hosp Psychiatry 2008, 30(2):155–161.
18. Hoth KF, Paulsen JS, Moser DJ, Tranel D, Clark LA, Bechara A: Patients with
Huntington's disease have impaired awareness of cognitive, emotional,
and functional abilities. J Clin Exp Neuropsychol 2007, 29(4):365–376.
19. Snowden JS, Craufurd D, Griffiths HL, Neary D: Awareness of involuntary
movements in Huntington disease. Arch Neurol 1998, 55(6):801–805.
20. Boecker H, Ceballos-Baumann A, Bartenstein P, Weindl A, Siebner HR,
Fassbender T, Munz F, Schwaiger M, Conrad B: Sensory processing in
Parkinson's and Huntington's disease: investigations with
3D H(2)(15)O-PET. Brain 1999, 122(Pt 9):1651–1665.
21. Saft C, Schuttke A, Beste C, Andrich J, Heindel W, Pfleiderer B: fMRI reveals
altered auditory processing in manifest and premanifest Huntington's
disease. Neuropsychologia 2008, 46(5):1279–1289.
22. Andrich J, Schmitz T, Saft C, Postert T, Kraus P, Epplen JT, Przuntek H,
Agelink MW: Autonomic nervous system function in Huntington's
disease. J Neurol Neurosurg Psychiatry 2002, 72(6):726–731.
23. Kobal J, Melik Z, Cankar K, Bajrovic FF, Meglic B, Peterlin B, Zaletel M:
Autonomic dysfunction in presymptomatic and early symptomatic
Huntington's disease. Acta Neurol Scand 2010, 121(6):392–399.
24. Petersen A, Bjorkqvist M: Hypothalamic-endocrine aspects in Huntington's
disease. Eur J Neurosci 2006, 24(4):961–967.
25. Bjorkqvist M, Petersen A, Bacos K, Isaacs J, Norlen P, Gil J, Popovic N,
Sundler F, Bates GP, Tabrizi SJ, et al: Progressive alterations in the
hypothalamic-pituitary-adrenal axis in the R6/2 transgenic mouse model
of Huntington's disease. Hum Mol Genet 2006, 15(10):1713–1721.
26. Andrich JE, Wobben M, Klotz P, Goetze O, Saft C: Upper gastrointestinal
findings in Huntington's disease: patients suffer but do not complain.
J Neural Transm 2009, 116(12):1607–1611.
27. Polzer I, Schwahn C, Volzke H, Mundt T, Biffar R: The association of tooth loss
with all-cause and circulatory mortality. Is there a benefit of replaced teeth? A
systematic review and meta-analysis. Clin Oral Investig 2012, 16(2):333–51.
28. Hoke M, Schillinger T, Mlekusch W, Wagner O, Minar E, Schillinger M: The
impact of dental disease on mortality in patients with asymptomatic
carotid atherosclerosis. Swiss Med Wkly 2011, 141:w13236.
29. Sadeghi M, Lynch CD, Arsalan A: Is there a correlation between dental
caries and body mass index-for-age among adolescents in Iran?
Community Dent Health 2011, 28(2):174–177.
30. Mucci LA, Hsieh CC, Williams PL, Arora M, Adami HO, de Faire U, Douglass
CW, Pedersen NL: Do genetic factors explain the association between
poor oral health and cardiovascular disease? A prospective study among
Swedish twins. Am J Epidemiol 2009, 170(5):615–621.31. Christen AG, Christen JA: Theodore Roosevelt's "presidential smile" and
questionable dental health. J Hist Dent 2007, 55(2):85–90.
32. Ocampo Flores P, Limon Mejia AL, Bustillos Lucas J, Silva Sanchez V: Death
from generalized sepsis of dental origin. Contribution to clinical
casuistry. Rev ADM 1991, 48(1):45–51.
33. Lanska DJ, Lanska MJ, Lavine L, Schoenberg BS: Conditions associated with
Huntington's disease at death. A case–control study. Arch Neurol 1988,
45(8):878–880.
34. Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS: Huntington's disease
mortality in the United States. Neurology 1988, 38(5):769–772.
doi:10.1186/1471-2377-13-114
Cite this article as: Saft et al.: Oral and dental health in Huntington‘s
disease - an observational study. BMC Neurology 2013 13:114.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
